Vovantis Laboratories
Loading...

About Us

Home About Company
Vovantis Mega Manufacturing Campus
16+
Years of Excellence
Effervescent CDMO Pioneers • Est. 2008
Our Heritage & Ethos

Driven by Science, Certified by Global Standards

Vovantis Laboratories Pvt. Ltd. was established with an audacious vision: to create world-class effervescent healthcare solutions capable of competing on the most rigorous global pharmaceutical stages.

Today, operating from our state-of-the-art dual-unit campus in Ranoli, Vadodara, we partner with multinational pharmaceutical leaders across the US, Europe, and emerging markets. Our specialized manufacturing facility maintains environmental relative humidity below 20% across all suites, enabling flawless production of highly sensitive, moisture-reactive effervescent tablets.

USFDA Audited Infrastructure
WHO-GMP & ISO Certified
120,000+ Sq. Ft. Facility
Supplying to 35+ Countries
Guiding Principles

Purpose-Built for Global Impact

Every formulation developed and batch manufactured at Vovantis is anchored by unwavering commitments to safety, efficacy, and regulatory compliance.

Our Mission

To innovate, formulate, and manufacture accessible, high-bioavailability effervescent and solid oral pharmaceuticals that substantially improve global patient compliance and well-being.

Our Vision

To be recognized worldwide as the definitive partner of choice for specialized effervescent drug delivery, pioneering breakthroughs through scientific diligence and manufacturing prowess.

Our Core Values

Scientific rigor, absolute regulatory integrity, transparency in CDMO partnerships, and continuous investment in world-class human capital and cleanroom automation.

Evolution & Growth

Our Journey of Continuous Innovation

From humble beginnings in 2008 to a world-class manufacturing complex serving global markets.

2008
Incorporation & Foundation

Vovantis Laboratories was founded with a dedicated charter to specialize in novel effervescent formulation science in Ranoli, Vadodara.

2013
Unit-1 Facility Commissioning

Completed construction of our registered manufacturing plant with integrated climate-controlled suites, specialized granulation, and high-speed tube filling lines.

2018
WHO-GMP & Global Expansion

Achieved WHO-GMP certification and established long-term private label and CDMO supply partnerships across 20+ countries in Southeast Asia, Africa, and Latin America.

2022
Unit-2 Mega Campus Expansion

Inaugurated Unit-2 factory campus, bringing total manufacturing footprint to 120,000+ sq. ft. equipped with dynamic dehumidification maintaining RH < 20%.

2024
Successful USFDA Audit

Successfully completed rigorous USFDA regulatory inspection with zero 483 observations, solidifying Vovantis as an elite supplier for US regulated markets.

2026
Continuous Granulation & Next-Gen CDMO

Deploying cutting-edge continuous effervescent processing, AI-powered automated visual inspection, and high-barrier packaging to scale global delivery.

Vadodara Manufacturing Hub

Engineered for Precision: Ranoli Mega Campus

Strategically situated along Gujarat’s premier pharmaceutical manufacturing corridor, our Ranoli campus consists of two specialized facilities: Unit-1 (Registered Office & Plant) and Unit-2 (Factory).

Dynamic Climate Control (low RH)

Custom desiccant rotor HVAC units guarantee moisture-free air throughout compression and packaging suites.

Integrated Desiccant Cap Tube Lines

Fully automated tube loading, tablet counting, desiccant cap insertion, and induction sealing.

ICH Stability & Method Development

Full-fledged on-site analytical laboratory with HPLC, GC, dissolution apparatus, and climate chambers.

Automated Manufacturing Line
R&D Analytical Laboratory
Cleanroom Production Facility
Partner With Vovantis

Ready to Scale Your Pharmaceutical Formulation?

Connect with our technical business development and formulation science team to schedule a comprehensive facility audit or discuss turnkey effervescent & solid dosage CDMO development.

USFDA & WHO-GMP Compliant Turnkey CDMO & Dossiers Strict IP Confidentiality